Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Necrobiotic xanthogranuloma: response to chlorambucil.

Ryan E, Warren LJ, Szabo F.

Australas J Dermatol. 2012 May;53(2):e23-5. doi: 10.1111/j.1440-0960.2010.00710.x. Epub 2010 Oct 20.

PMID:
22571578
2.

Necrobiotic xanthogranuloma treated with chlorambucil.

Torabian SZ, Fazel N, Knuttle R.

Dermatol Online J. 2006 Sep 8;12(5):11.

PMID:
16962026
3.

Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil.

Machado S, Alves R, Lima M, Leal I, Massa A.

Eur J Dermatol. 2001 Sep-Oct;11(5):458-62. Review.

PMID:
11525957
4.

Necrobiotic xanthogranuloma.

Rose A, Robinson M, Kamino H, Latkowski JA.

Dermatol Online J. 2012 Dec 15;18(12):30.

5.

Necrobiotic xanthogranuloma with paraproteinaemia.

Flann S, Wain EM, Halpern S, Andrews V, Whittaker S.

Clin Exp Dermatol. 2006 Mar;31(2):248-51.

PMID:
16487104
6.
7.

Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.

Ghiasi N, Alavi A, Coutts PM, Ghazarian D, Sibbald RG.

Int J Low Extrem Wounds. 2012 Dec;11(4):293-5. doi: 10.1177/1534734612465434.

PMID:
23222162
8.

Successful treatment of necrobiotic xanthogranuloma with total glucosides of paeony.

Li S, Chen AJ, Fang S, Li H.

Dermatol Ther. 2014 Sep-Oct;27(5):304-6. doi: 10.1111/dth.12133. Epub 2014 Apr 28.

PMID:
24774012
9.

Necrobiotic xanthogranuloma of the extremities.

Wolz M, Peters MS.

J Drugs Dermatol. 2012 Jan;11(1):122-3. No abstract available.

PMID:
22206088
10.

An unusual histologic variant of necrobiotic xanthogranuloma.

Ziemer M, Norgauer J, Simon JC, Koehler MJ.

Am J Dermatopathol. 2012 Apr;34(2):e22-6. doi: 10.1097/DAD.0b013e3182222aa8.

PMID:
22441374
11.

Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.

Efebera Y, Blanchard E, Allam C, Han A, Lee S, Munshi N.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):298-302. doi: 10.1016/j.clml.2011.03.020. Epub 2011 Apr 20. Review.

12.

Long-term remissions with weekly chlorambucil therapy in patients with intermediate-risk chronic lymphocytic leukaemia.

Manoharan A.

Br J Haematol. 2002 Sep;118(4):1193-4. No abstract available.

PMID:
12199809
13.

Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.

Naghashpour M, Setoodeh R, Moscinski L, Bergier G, McCardle T, Glass F, Sokol L.

Am J Dermatopathol. 2011 Dec;33(8):855-7. doi: 10.1097/DAD.0b013e3182051fce.

PMID:
22042261
14.

Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin.

Rubinstein A, Wolf DJ, Granstein RD.

J Cutan Med Surg. 2013 Sep-Oct;17(5):347-50.

PMID:
24067856
15.

Treatment of necrobiotic xanthogranuloma with 2-chlorodeoxyadenosine.

Sutton L, Sutton S, Sutton M.

Skinmed. 2013 Mar-Apr;11(2):121-3.

PMID:
23745232
16.

Immunomodulatory drugs for the treatment of periorbital necrobiotic xanthogranuloma.

Abdul-Hay M.

Clin Adv Hematol Oncol. 2013 Oct;11(10):680-1. Review. No abstract available.

PMID:
24518383
18.

Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.

Ghani S, Al Ustwani O, Khalid B, Bogner P, Grassi M, Powell J, Bhat SA.

Clin Adv Hematol Oncol. 2013 Oct;11(10):678-80. No abstract available.

PMID:
24518382
19.

Acute polyneuropathy with chronic lymphocytic leukaemia and paraproteinaemia: response to chlorambucil and prednisolone.

Drake WM, Monson JP, Trainer PJ, Sharief M, Dick JP, Kelsey SM.

J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):564. No abstract available.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk